Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Sell
2,370
-1,148
-33% -$139K 0.02% 379
2026
Q1
$575K Sell
3,518
-1,217
-26% -$187K 0.05% 244
2025
Q4
$824K Sell
4,735
-692
-13% -$126K 0.07% 189
2025
Q3
$782K Buy
5,427
+222
+4% +$27.2K 0.07% 197
2025
Q2
$524K Sell
5,205
-677
-12% -$51.8K 0.05% 241
2025
Q1
$449K Buy
5,882
+316
+6% +$24.2K 0.04% 257
2024
Q4
$384K Buy
5,566
+600
+12% +$43.2K 0.04% 286
2024
Q3
$363K Buy
4,966
+138
+3% +$10.2K 0.04% 304
2024
Q2
$323K Buy
+4,828
New +$187K 0.03% 312

Other funds holding INSM

Intrust Bank's INSM Position: Q2 2026 in Review

Intrust Bank reduced its Insmed (INSM) stake by 33% in Q2 2026, selling an estimated $139K and leaving 2,370 shares worth $253K. The position accounts for 0.02% of the portfolio, ranked #379.

Intrust Bank first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $824K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Intrust Bank held 2,370 shares of Insmed worth $253K as of Q2 2026.
  • Intrust Bank sold 1,148 Insmed shares in Q2 2026, an estimated $139K.
  • Insmed made up 0.02% of Intrust Bank's portfolio in Q2 2026, its #379 holding.
  • Intrust Bank first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Intrust Bank's Insmed position peaked at $824K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.